In lung cancer patients who responded to PD-1/PD-L1 blocking, the expression of CD69 was upregulated, indicating that CD69 expression levels can effectively predict cancer response to PD-1/PD-L1 blockade immunotherapy46. The gene discussed is CD274; the disease is lung carcinoma.